InvestorsHub Logo
icon url

taketobank

11/02/16 5:37 PM

#7852 RE: CATTDOGG12347 #7851


And why only 3 people in the dose level 2... I wonder if the hold had anything to do with that? I'm just not sure of the timing of that.

So many trials to keep track of. I'm going to look at the most recent analyst reports.
icon url

huskercatman123

11/02/16 7:44 PM

#7853 RE: CATTDOGG12347 #7851

I have been an investor for over 7 years; and I continue to invest in this company. Bottom line you have to ask yourself if you or a family member were to be diagnosed with cancer (heaven forbid); what line of treatment would you pursue? For me and mine, we would be searching for an ADXS trial!

Catt, you have been here a long time; and I know that your also believe in this company!

icon url

James salmon

11/02/16 7:47 PM

#7855 RE: CATTDOGG12347 #7851

Catt,

This is one of the reasons why the addition of PD1 will increase survival, it will give these woman the chance to get a minimum of 3 doses, and we know that increase survival significantly.